Success Stories: Our Team Obtained NIW Approval for a Scientist from Sri Lanka in Just 3 Days, with No RFE Issued
Client’s Testimonial:
“This is really awesome news and thank you very much for everything to make this happen!”
On February 8th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Biochemistry (Approval Notice).
General Field: Biochemistry
Position at the Time of Case Filing: Scientist
Country of Origin: Sri Lanka
State of Residence at the Time of Filing: Ohio
Approval Notice Date: February 8th, 2024
Processing Time: 3 days (Premium Processing Requested)
Case Summary:
One of our most valued clients envisaged himself achieving his professional goals in the United States without having to deal with any extra Requests for Evidence (RFE). His wish came true when the North America Immigration Law Group agreed to assist him in getting his NIW petition granted without any complications. Our careful team examined his extensive study experience and strong qualifications in the biochemistry field that he chose. As a result, we highlighted our client's extraordinary success story, assisting him in securing a National Interest Waiver in just 3 days without incurring an RFE.
We added the following information to his NIW petition packet:
- The Client's Proposed Endeavor- As an expert in the field of biochemistry, our client proposed to continue his research on developing new methodologies for engineering and characterizing novel proteins and antibodies in order to further biomedical studies, the biotechnology industry, and healthcare.
- The Great Substantial Merit and National importance of his research- We deduced that his research advancing his proposed endeavor is of great importance because it provides the foundation for innovations in biotechnology, biomedicine, and healthcare that add significant value to the global economy.
- Funding Support- It is worth noting that his study has received funding from a reputable organization, such as the National Institutes of Health (NIH). This funding support therefore serves as evidence that he has delivered key insights into the medicinal properties of natural products to advance the development of novel therapeutic treatments for a range of human ailments.
- Publishing, Citation, and Peer-Reviews Experience- In addition, we underlined that he has published 3 peer-reviewed journal articles (1 of them first-authored) 1 first-authored conference abstract, and 1 preprint in authoritative peer-reviewed journals. His peers have cited his work 17 times, indicating both the originality and effectiveness of his methods and results.
- Accomplished Victory- The innovative protein and antibody engineering developments by our client are paving the way for health-enhancing technologies, ultimately allowing the healthcare and pharmaceutical sectors to thrive and provide populations with better health services. His advances are also crucial for driving U.S. leadership in protein engineering technology and applications, enhancing health outcomes across the nation. Therefore, the adjudication officers have acknowledged the significance of our client’s proposed endeavor, which has bolstered public health and the U.S. economy.